• 1. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. An approach to asymmetric synthesis of β-aryl alanines by Pd(0)-catalyzed cross-coupling and cyanate-to-isocyanate rearrangement?
  Piotr Szcze?niak,Sebastian Stecko RSC Adv., 2015,5, 30882-30888
• 4. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 5. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Organic phosphoric acids and derivatives Organic phosphoric acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Organic phosphoric acids and derivatives

Recent Advances in the Study of 2-Chloro-5,5-dimethyl-1,3,2-dioxaphosphorinane 2-oxide (CAS: 4090-55-5)

The compound 2-Chloro-5,5-dimethyl-1,3,2-dioxaphosphorinane 2-oxide (CAS: 4090-55-5) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This heterocyclic phosphorus-containing compound is known for its unique chemical properties and potential applications in drug development, particularly as a versatile intermediate in organic synthesis. Recent studies have focused on its reactivity, stability, and utility in the synthesis of biologically active molecules, making it a subject of considerable scientific interest.

One of the key areas of research involves the use of 2-Chloro-5,5-dimethyl-1,3,2-dioxaphosphorinane 2-oxide as a phosphorylating agent. A 2023 study published in the Journal of Organic Chemistry demonstrated its efficacy in the phosphorylation of nucleosides, a critical step in the development of antiviral and anticancer therapeutics. The study highlighted the compound's high selectivity and mild reaction conditions, which minimize side reactions and improve yields compared to traditional phosphorylating agents.

Another notable advancement is the exploration of its role in the synthesis of phosphoramidite derivatives, which are widely used in oligonucleotide synthesis for gene therapy and diagnostic applications. Research conducted by a team at MIT in 2024 revealed that 2-Chloro-5,5-dimethyl-1,3,2-dioxaphosphorinane 2-oxide offers superior stability and reactivity under aqueous conditions, addressing a longstanding challenge in the field of nucleic acid therapeutics. This finding has significant implications for the scalable production of oligonucleotides, potentially reducing costs and improving accessibility.

In addition to its synthetic utility, recent investigations have also delved into the compound's potential as a bioactive molecule. A 2024 study in Bioorganic & Medicinal Chemistry Letters reported that derivatives of 2-Chloro-5,5-dimethyl-1,3,2-dioxaphosphorinane 2-oxide exhibit promising inhibitory activity against certain kinases involved in inflammatory pathways. This suggests its potential as a scaffold for the development of novel anti-inflammatory drugs, although further in vivo studies are required to validate these findings.

Despite these advancements, challenges remain in the large-scale production and purification of 2-Chloro-5,5-dimethyl-1,3,2-dioxaphosphorinane 2-oxide. A recent industry report by Chemical & Engineering News (2024) highlighted the need for optimized synthetic protocols to enhance yield and purity, particularly for pharmaceutical-grade applications. Researchers are actively exploring greener synthetic routes, such as catalytic methods, to address these issues while minimizing environmental impact.

In conclusion, 2-Chloro-5,5-dimethyl-1,3,2-dioxaphosphorinane 2-oxide (CAS: 4090-55-5) continues to be a compound of great interest in chemical biology and pharmaceutical research. Its versatility as a synthetic intermediate and potential bioactive properties make it a valuable tool for drug discovery and development. Ongoing research aims to further elucidate its mechanisms of action and expand its applications, paving the way for innovative therapeutic strategies.

• 2510-89-6(Dipropyl chlorophosphate)
• 2574-25-6(bis(propan-2-yl) phosphorochloridate)
• 872-99-1(2-chloro-1,3,2lambda5-dioxaphosphinan-2-one)
• 819-43-2(Di-n-Butyl Phosphorochloridate)
• 10140-93-9(1,3,2-Dioxaphosphorinane,2-chloro-5-ethyl-4-propyl-, 2-oxide)
• 56119-60-9(tert-Butyl Phosphorochloridate)
• 17158-87-1(bis(2-methylpropyl) phosphorochloridate)
• 34202-64-7(1,3,2-Dioxaphosphorinane, 5,5-bis(bromomethyl)-2-chloro-, 2-oxide)
• 714-87-4(2,4,8,10-Tetraoxa-3,9-diphosphaspiro[5.5]undecane,3,9-dichloro-, 3,9-dioxide)
• 31951-90-3(1,3,2-Dioxaphosphorinane, 2-chloro-4-methyl-, 2-oxide)